Aspire BioPharma is trading 5.5% lower at $7.84, with no clear catalyst established. - The price is down from the October 9 close of $8.30, marking the largest single-session move in the recent seven-day history. - No company-specific announcement dated October 12 appeared in the company’s press-release listing, and market coverage showed no Dow Jones headlines for the stock. Broader indexes were mixed, with modest moves.